-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The 40th JP Morgan Healthcare Conference will be held online from January 10-13, 2022
Twist Enzymatic DNA Synthesis 3.
For the past 18 months, Twist scientists have been working to develop a new method of enzymatically synthesizing strands of DNA
Dr Leproust said: "The culture we innovated and executed has once again achieved a breakthrough in DNA synthesis, this time using enzymes
"Today, we use phosphoramidite chemistry within a stable commercial structure, delivering multi-billion-base DNA and RNA products to nearly 3,000 customers in fiscal 2021 alone
Partnership with PacBio and Singular Genomics
Twist also announced that it is partnering with PacBio and Singular Genomics to advance the next-generation sequencing (NGS) process
"Partnering with a leading company in next-generation sequencing that is driving the industry is in line with our strategy to have a competitive landscape between samples and sequencers," continued Dr.
About Twist Bioscience
Twist Bioscience is a leading and fast-growing synthetic biology and genomics company developing disruptive DNA synthesis platforms to advance the industrialization of bioengineering